Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.25 USD | +8.70% | -7.02% | -25.25% |
06-24 | Omega Therapeutics, Inc. Appoints Richard N. Kender to Board of Directors | CI |
06-18 | Raymond James Initiates Omega Therapeutics at Outperform Rating With $12 Price Target | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.25% | 124M | |
+16.59% | 44.44B | |
-9.89% | 37.99B | |
+38.08% | 37.75B | |
+27.12% | 30.78B | |
-8.64% | 27.38B | |
+11.81% | 26.17B | |
+45.08% | 14.15B | |
+32.85% | 12.59B | |
-7.19% | 11.28B |
- Stock Market
- Equities
- OMGA Stock
- News Omega Therapeutics, Inc.
- Transcript : Omega Therapeutics, Inc. Presents at Jefferies Cell and Genetic Medicine Summit, Sep-30-2022 09